Home › Funds › UBS Group AG › BCLI
UBS Group AG position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q2 2025)12.38K sh
Reported value held$13.87K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 11.01K | $37.00K | New |
| Q4 2021 | 14.41K | $58.00K | Add |
| Q1 2022 | 7.71K | $26.00K | Reduce |
| Q2 2022 | 7.79K | $22.00K | Add |
| Q3 2022 | 7.50K | $33.00K | Reduce |
| Q4 2022 | 7.50K | $12.30K | Hold |
| Q1 2023 | 7.50K | $24.75K | Hold |
| Q2 2023 | 2.50K | $5.15K | Reduce |
| Q3 2023 | 3.64K | $728 | Add |
| Q4 2023 | 2.50K | $683 | Reduce |
| Q1 2024 | 2.50K | $1.41K | Hold |
| Q2 2024 | 7.11K | $2.41K | Add |
| Q3 2024 | 2.50K | $575 | Reduce |
| Q4 2024 | 3.47K | $7.88K | Add |
| Q1 2025 | 253 | $319 | Reduce |
| Q2 2025 | 12.38K | $13.87K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.